- Home
- WALD vs NPCE Comparison
WALD vs NPCE Comparison
Compare WALD & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- NPCE
- Stock Information
- Founded
- WALD 1988
- NPCE 1997
- Country
- WALD United States
- NPCE United States
- Employees
- WALD N/A
- NPCE N/A
- Industry
- WALD Package Goods/Cosmetics
- NPCE Medical Specialities
- Sector
- WALD Consumer Discretionary
- NPCE Health Care
- Exchange
- WALD Nasdaq
- NPCE Nasdaq
- Market Cap
- WALD 306.3M
- NPCE 292.9M
- IPO Year
- WALD 2021
- NPCE 2021
- Fundamental
- Price
- WALD $1.56
- NPCE $9.15
- Analyst Decision
- WALD Strong Buy
- NPCE Strong Buy
- Analyst Count
- WALD 5
- NPCE 6
- Target Price
- WALD $4.96
- NPCE $16.67
- AVG Volume (30 Days)
- WALD 528.0K
- NPCE 205.3K
- Earning Date
- WALD 11-11-2025
- NPCE 08-12-2025
- Dividend Yield
- WALD N/A
- NPCE N/A
- EPS Growth
- WALD N/A
- NPCE N/A
- EPS
- WALD N/A
- NPCE N/A
- Revenue
- WALD $273,868,000.00
- NPCE $88,570,000.00
- Revenue This Year
- WALD $10.37
- NPCE $22.13
- Revenue Next Year
- WALD $14.37
- NPCE $6.07
- P/E Ratio
- WALD N/A
- NPCE N/A
- Revenue Growth
- WALD 25.55
- NPCE 23.32
- 52 Week Low
- WALD $1.50
- NPCE $5.45
- 52 Week High
- WALD $4.40
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- WALD 35.98
- NPCE 51.74
- Support Level
- WALD $1.50
- NPCE $8.61
- Resistance Level
- WALD $1.79
- NPCE $8.99
- Average True Range (ATR)
- WALD 0.16
- NPCE 0.53
- MACD
- WALD 0.00
- NPCE 0.11
- Stochastic Oscillator
- WALD 10.00
- NPCE 75.00
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.